Julie Burgess is the chief accounting officer at Design Therapeutics. Ms. Burgess brings more than 25 years of experience in financial reporting, technical accounting, debt and equity financings, and financial planning and management for public and private biotechnology companies. Prior to Design, Ms. Burgess served as the senior vice president of finance at Otonomy, Inc., Corporate Controller at Apricus Biosciences, and a consultant to several other biopharmaceutical companies. Ms. Burgess is a licensed CPA and completed her MBA at San Diego State University.